Pharmaceuticals (Nov 2024)

Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918

  • Medhat Taha,
  • Sara T. Elazab,
  • Alaa. M. Badawy,
  • Abdullah A. Saati,
  • Naeem F. Qusty,
  • Abdullah G. Al-Kushi,
  • Anas Sarhan,
  • Amira Osman,
  • Amira E. Farage

DOI
https://doi.org/10.3390/ph17111533
Journal volume & issue
Vol. 17, no. 11
p. 1533

Abstract

Read online

In the original publication [...]

Keywords